Christiansen Leif E DO is categorized under Internal Medicine Practitioners in Reading, PA and active since 1989.
Christiansen Leif E DO was established in 1989, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Leif Christiansen at the company’s single location by writing to 2234 Perkiomen Avenue, Reading, Pennsylvania PA 19606 or by phoning (610) 370-2511. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Christiansen Leif E DO |
| Contact Person: | Leif Christiansen |
| Address: | 2234 Perkiomen Avenue, Reading, Pennsylvania 19606 |
| Phone Number: | (610) 370-2511 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1989 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Practitioners |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Christiansen Leif E DO was started in 1989 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Leif Christiansen for inquiries that concern Christiansen Leif E DO by calling the company number (610) 370-2511, as your correspondence is most welcome. Additionally, the physical location of the single location of Christiansen Leif E DO can be found at the coordinates 40.32783,-75.8926 as well as the street address 2234 Perkiomen Avenue in Reading, Pennsylvania 19606.
For its online presence, you may visit Christiansen Leif E DO’s website at and engage with its social media outlets through on Twitter and on Facebook.